VIENNALAB - Established innovations in diagnostics

Differences in the activity of the liver enzyme CYP2D6 contribute to the inter-individual variability in drug response. The PGX-CYP2D6 StripAssay® detects the most common variants with impaired enzyme activity.

PGX-CYP2D6 StripAssay®

  • The liver enzyme CYP2D6 is responsible for the metabolism of about 25% of all currently prescribed drugs
  • Around 7% of Caucasians carry defective alleles that result in partially or completely inactive enzymes
  • Knowing the metabolizer status of a patient allows a better prediction of adverse side effects and suboptimal treatment efficacy
  • CYP2D6 genotyping helps to determine the optimum type and dosage of drugs for specific disorders

Product Details

PGX-CYP2D6 StripAssay® ref4-760